NEW YORK--(BUSINESS WIRE)--
Rosen Law Firm, a global investor rights law firm, announces it is investigating potential securities claims on behalf of investors of Axon Enterprise, Inc. (“Axon”) (NASDAQ:AAXN) resulting from allegations that Axon may have issued materially misleading business information to the investing public.
On October 19, 2017, Axon announced during aftermarket hours that the U.S. Securities and Exchange Commission (“SEC”) is reviewing its financial statements. Specifically, the SEC issued three letters in August and September seeking additional information relating to Axon’s Form 10-K for the year ended December 31, 2016 and Form 10-Q for the quarter ended March 31, 2017. In the SEC’s third letter dated September 20, 2017, it stated its inquiries remained “outstanding and unresolved, and absent a substantive response, we would act consistent with our obligations under the federal securities laws.” On this news, shares of Axon fell $1.61 per share or over 6% to close at $23.01 per share on October 20, 2017.
Rosen Law Firm is preparing a class action lawsuit to recover losses suffered by Axon investors. If you purchased shares of Axon, please visit the firm’s website at http://www.rosenlegal.com/cases-1220.html for more information. You may also contact Phillip Kim or Kevin Chan of Rosen Law Firm toll free at 866-767-3653 or via email at [email protected] or [email protected].
Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm or on Twitter: https://twitter.com/rosen_firm.
Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Since 2014, Rosen Law Firm has been ranked #2 in the nation by Institutional Shareholder Services for the number of securities class action settlements annually obtained for investors.
Attorney Advertising. Prior results do not guarantee a similar outcome.
View source version on businesswire.com: http://www.businesswire.com/news/home/20171023006031/en/
